On 6 August 2016
Venus Remedies will hold a meeting of the Board of Directors of the Company on 6 August 2016, to approve the Unaudited financial results (provisional) for the quarter ended 30 June 2016, & to issue fully convertible warrants/equity shares to promoters on a preferential basis subject to approval in the general meeting.Powered by Capital Market - Live News
